First-line nivolumab plus ipilimumab with two cycles of chemotherapy versus chemotherapy alone (four cycles) in advanced non-small-cell lung cancer: CheckMate 9LA 2-year update

JOURNAL ARTICLE published October 2021 in ESMO Open

Authors: M. Reck | T.-E. Ciuleanu | M. Cobo | M. Schenker | B. Zurawski | J. Menezes | E. Richardet | J. Bennouna | E. Felip | O. Juan-Vidal | A. Alexandru | H. Sakai | A. Lingua | F. Reyes | P.-J. Souquet | P. De Marchi | C. Martin | M. Pérol | A. Scherpereel | S. Lu | L. Paz-Ares | D.P. Carbone | A. Memaj | S. Marimuthu | X. Zhang | P. Tran | T. John